Caris Life Sciences (CAI) Non Operating Income (2024 - 2026)

Caris Life Sciences' Non Operating Income history runs 3 years deep, the most recent figure standing at -$5.9 million for Q1 2026.

• In Q1 2026, Non Operating Income rose 86.72% year-over-year to -$5.9 million; the TTM figure through Mar 2026 stood at -$70.2 million (down 56.74% YoY), while the FY2025 annual figure was -$20.6 million, down 5791.12% from the prior year.
• Non Operating Income was -$5.9 million for Q1 2026 at Caris Life Sciences, down from -$2.1 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $37000.0 in Q3 2024 to a low of -$53.8 million in Q2 2025.
• Historically, Non Operating Income has averaged -$14.4 million across 3 years, with a median of -$4.0 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Non Operating Income tumbled 38056.74% in 2025, then soared 86.72% in 2026.
• A 3-year view of Non Operating Income shows it stood at -$26000.0 in 2024, then slumped by 8026.92% to -$2.1 million in 2025, then slumped by 180.45% to -$5.9 million in 2026.
• The last three Non Operating Income figures came in at -$5.9 million (Q1 2026), -$2.1 million (Q4 2025), and -$8.3 million (Q3 2025), per Business Quant data.